Middle East, North Africa, Afghanistan & Pakistan vs Romania: Antiretroviral therapy coverage for PMTCT
Middle East, North Africa, Afghanistan & Pakistan
24.6%
in 2019
Romania
96.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan rank
13th
Romania rank
15th
Antiretroviral therapy coverage for PMTCT over time
- Middle East, North Africa, Afghanistan & Pakistan
- Romania
How they compare
Romania currently reports 96.0% against 24.6% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 71.4%.
That makes Romania's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan's.
The two have swapped places 2 times across 19 shared years of data; in 2000 it was Romania ahead.
Middle East, North Africa, Afghanistan & Pakistan ranks 13th and Romania ranks 15th of 15 groups.
Romania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 21.8% | 18.7% | Romania |
| 2010s | 16.8% | 86.2% | 69.4% | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Middle East, North Africa, Afghanistan & Pakistan or Romania?
- Romania, at 96.0% against 24.6% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Middle East, North Africa, Afghanistan & Pakistan and Romania?
- 71.4%, with Romania ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Romania?
- 19 years are reported by both, from 2000 to 2019.
- How do Middle East, North Africa, Afghanistan & Pakistan and Romania rank globally for antiretroviral therapy coverage for pmtct?
- Middle East, North Africa, Afghanistan & Pakistan ranks 13th and Romania ranks 15th of 15 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).